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ABSTRACT
PURPOSE: Evaluate the effect of N-acetylcysteine in liver remnant after hepatectomy associated to ischemia-reperfusion injury 
in mice. 
METHODS: Male adult BALB/c mice, weighing 20-22g were used. Animals were anesthetized with ketamine (70 mg/kg) and xylazine 
(10 mg/kg); received N-acetylcysteine (150 mg/kg, H-IR-NAC group) or vehicle (H-IR group). Surgical procedures were performed 
under 10X magnification. Partial hepatectomy (30%) was followed by ischemia-reperfusion injury (30 minutes of ischemia and 60 
minutes of reperfusion). Blood sample and liver tissue were removed before animal was euthanized. AST and ALT were evaluated in 
blood samples and histomorphological analyses were performed in remnant liver. Groups were compared by Mann-Whitney test, and it 
was considered significant when p<0.05.
RESULTS: Biochemical evaluations showed reduced levels of ALT in NAC group (H-IR-NAC=376±127U/l vs H-IR=636±39U/l, 
p=0.023). AST was similar (p=0.456). H-IR group showed hepatic tissue with preserved architecture, large area of steatosis, vascular 
congestion and rare mitogenic activity. NAC group showed hepatic tissue with small area of steatosis, vascular congestion and elevated 
mitogenic activity, evidenced by increased binuclear cells (H-IR-NAC=15.88±0.52 vs H-IR=7.4±0.37, p<0.001). 
CONCLUSION: N-acetylcysteine promotes enzymatic and morphological protection against hepatectomy and ischemia-reperfusion 
injury.
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RESUMO
OBJETIVO: Investigar se a N-acetilcisteína promove proteção do remanescente hepático após ressecção associada à isquemia e 
reperfusão do fígado em camundongos. 
MÉTODOS: Foram utilizados 12 camundongos BALB/c, machos, pesando entre 20-22g. Os animais foram anestesiados com 
quetamina (70mg/kg) e xilazina (10mg/kg); receberam a N-acetilcisteína (150mg/kg, grupo H-IR-NAC) ou controle (grupo H-IR). Os 
procedimentos cirúrgicos ocorreram na magnificação de 10X. A lesão por isquemia e reperfusão (30 minutos de isquemia e 60 minutos 
de reperfusão) foi precedida pela hepatectomia de 30%. Foram utilizados como parâmetro de avaliação: a bioquímica sangüínea (AST 
e ALT) e a histologia do fígado (coloração de hematoxilina-eosina). Para avaliação estatística empregou-se o teste de Mann-Whitney e 
o nível de significância foi 5%. 
RESULTADOS: Na avaliação bioquímica houve redução no nível de ALT no grupo tratado (H-IR-NAC=376±127 U/l vs H-IR=636±39 
U/l, p=0,023). AST foi similar (p=0,456). Na histologia, o grupo H-IR apresentou um tecido hepático com arquitetura preservada, com 
grandes áreas de infiltração gordurosa, presença de congestão vascular e de alguma atividade mitótica; o grupo com a N-acetilcisteína 
apresentou menor infiltração gordurosa e congestão vascular, maior atividade mitótica, evidenciada pela quantidade elevada de células 
binucleadas (H-IR-NAC=15,88±0,52 vs H-IR=7,4±0,37, p<0,001). 
CONCLUSÃO: A N-acetilcisteína promove proteção ao fígado, do ponto de vista morfológico e enzimático , após hepatectomia 
associada à isquemia e reperfusão
Descritores: Acetilcisteína. Traumatismo por Reperfusão. Hepatectomia. Camundongos.
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Introduction
The mortality in the transplant waiting list is still very 
high, due to scarcity of compatible donors for pediatric recipient1. 
Some solutions have been made to increase the number of 
disposable graft: adult liver reduction, division of cadaver liver 
providing two possible grafts, or use of grafts from live donors1-3. 
All of these techniques contributed to improve the number of 
liver grafts. In the other hand, the existing disproportion between 
graft and recipient is still a relevant problem: the inappropriate 
size brings hemodynamic and functional implications, occurring 
primary non-function or dysfunction3.
The ischemia-reperfusion lesion related to liver surgery 
and transplantation, in association to volume of parenchyma 
reduction, can synergically compromise the organ, stimulating 
laboratorial research to overcome such problems2-4.
Antioxidative vitamins, enzymes or other free radical 
scavengers have been shown diminish or neutralize oxygen and 
nitrogen free radicals5,6. A low weight thiol, the N-acetylcysteine 
(NAC), has its use established in the acetaminophen intoxication, 
protecting the liver by increasing hepatic glutathione7.
NAC has been used in clinical practices in situations as 
hemodynamic instabilities, protecting hepatic, pulmonary, cardiac 
and renal tissues, compromised by ischemia and reperfusion. 
This applicability is supported by experimental animal studies, 
some done by our research team that showed local and systemic 
protection after ischemia-reperfusion injury8-10. NAC acts like an 
antioxidant beyond improving blood flow in microcirculation11.
Since N-acetylcysteine shows protective action against 
ischemia and reperfusion lesion and that manipulation of 
liver promotes microcirculation changes, modifying the organ 
perfusion, it was decided to evaluate if N-acetylcysteine promotes 
protection to remnant liver after hepatectomy of 30% associated to 
liver ischemia-reperfusion injury in mice.
Methods
The experimental protocol was submitted and 
approved by UNIFESP Ethics Committee on Animal Research 
(CEP#1945/07). It was used twelve adult male BALB/c mice 
supplied by the Experimental Animal Center of UNIFESP, ranging 
in age from six to eight weeks and weighing 20-22g. The animals 
were randomly allocated into two groups: group H-IR (n = 6) 
subjected to hepatectomy + ischemia/reperfusion; group H-IR-
NAC (n = 6) pretreated with N-acetylcysteine (NAC) (150 mg/kg) 
and then hepatectomy+ischemia/reperfusion, as for the preceding 
group.
Animal preparation consisted of ketamine and xylazine 
anesthesia (70 and 10 mg.kg−1, respectively) intramuscularly, 
followed by a midline laparotomy and hydration with 
warm saline solution (3 mL. kg−1. h−1). Animals were kept 
over a heating pad during all experimental procedures. 
 
The surgical procedures were performed as follows: 
Ischemia/Reperfusion
Fifteen minutes after laparotomy, the hepatic hilum was 
occluded for 30 minutes with an atraumatic clip placed across 
it interrupting the blood supply, followed by 60 minutes of 
reperfusion. 
Hepatectomy
During the occlusion, 30% of the liver (right lobes, 
caudate lobe and quadrate process) was excised, as previously 
described12. NAC: animals from this group were treated with 
intravenous (IV) infusion of NAC (150 mg.kg−1) through vena 
cava 15 minutes prior to the 30-minute ischemic period and 5 
minutes before the 60 minutes of reperfusion. 
After reperfusion, blood was drawn for biochemical 
analysis. Part of median liver lobes was removed and immediately 
fixed in 10% formaldehyde. Routine histological processes were 
employed for paraffin inclusion, sectioning and hematoxyline-
eosine staining. 
Histological aspects
The hepatic aspect was evaluated considering the 
presence of vascular congestion and fat infiltration, mitotic activity 
and binuclear nucleus within hepatocytes. The comparison of this 
last evaluation was made by counting cells with binuclear nucleus 
in 1000 hepatocytes per animal. Appropriate image capture was 
made using a light microscope (Axiolab Standart 20, Carl Zeiss, 
Jena, Germany) coupled to a video camera (AxionCam, Carl 
Zeiss, Jena, Germany).
Biochemical dosage
The sampled blood was centrifuged and the sera 
were used for aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) determinations, using Cobas Mira.
Statistical analysis
Nonparametric statistical tests were used to compare 
differences between experimental groups. Values are considered 
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significantly different for p≤0.05.
Results
The hepatectomy + ischemia/reperfusion group (H-
IR) presented a preserved hepatic architecture. However, it was 
observed presence of vascular congestion, hepatocytes with 
cytoplasmatic light areas, indicating lipidic infiltration (Figure 
1A). In hepatectomy + ischemia/reperfusion group treated with 
N-acetylcysteine (H-IR-NAC), liver parenchyma showed lower 
vascular congestion and hepatocytes with diminished cytoplasmatic 
light areas, and presence of several binucleated hepatocytes, some 
with large nucleus (Figure 1B). Also, NAC treatment improved 
the number of binucleated hepatocytes: H-IR=7.402±0.372 and 
H-IR-NAC=15.88±0.523 (p< 0,001) (Figure 2).
FIGURE 1 - Photomicrographs showing part of the mice liver lobes. 
A. From H-IR (Hepatectomy + ischemia / reperfusion) group. Notice 
hepatocytes with cytoplasmatic light areas (¤) and vascular congestion 
(arrow). B. From H-IR-NAC (Hepatectomy + ischemia / reperfusion 
treated with N-acetylcysteine) group. Notice large nucleus (arrow) and 
hepatocytes containing binuclear nucleus (*). H.E.
FIGURE 2 - Calculated percentage of binuclear hepatocytes (p<0.001).
NAC treatment decreased both of the enzyme 
activities, but only ALT was statistically significant. ALT: 
H-IR=636±39.1U/L and H-IR-NAC=376±127.3U/L (*p=0.023) 
/ AST: H-IR=1259±304 U/L and H-IR-NAC=985± 347U/L 
(p=0.456) (Figure 3).
FIGURE 3 - Values of aspartate aminotransferase (AST; p=0.456) and 
alanine aminotransferase (ALT; *p=0.023) in both groups.
Discussion
There are numerous potential mechanisms of action by 
which NAC may exert protective effects13. But the interesting 
about this experiment was to see the enormous increase in binuclear 
hepatocytes, after use of NAC. Due to the liver fast metabolism, 
it is very common to appear polyploidy nucleus (having higher 
genetic load than normal), so more transcriptions happen. In our 
study, part of the liver was excised, leading to over function of the 
remaining hepatocytes. The increase in this short period of time 
(about two hours) is exciting, because N-acetylcysteine could not 
only protect but help in recovery.
James et al.14 observed that IL-6 was increased 
because of N-acetylcysteine in the liver tissue, denoting a 
mitogenic stimulus, as well. Glantzounis et al.18 showed that 
microcirculation and alanine aminotransferase activity were 
better when N-acetylcysteine was used, corroborating our findings 
related to vascular congestion in the parenchyma and ALT levels. 
It has been proposed that nitric oxide has an important role in the 
vascular congestion improvement induced by N-acetylcysteine15. 
Hogg et al.15 proposed a protective mechanism by low weight 
thiol, in which nitric oxide reacts with glutathione, improving 
the microcirculation, attenuating vascular congestion and tissue 
injury. Also ALT level was lower after NAC use. AST and ALT are 
useful screening tests for detecting liver injury. They are found in 
hepatocytes and cannot diffuse out of the cells in the physiological 
condition. When the hepatocyte is injured, plasma membrane can 
be disrupted and the leakage through extracellular fluid of the 
enzyme occurs where they can be detected at abnormal levels in 
the serum.  So the ALT reduction could be the protection given by 
N-acetylcysteine as suggested previously14. 
The ischemia-reperfusion lesion associated to liver 
transplantation can synergically compromise the organ after 
transplant. It is in this context that N-acetylcysteine, as protective 
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strategy, could minimize the lesion, promoting best functionality 
of the graft. Further experiments are currently under way to 
address this hypothesis.
Conclusion
The N-acetylcysteine promotes protection to the remnant 
liver after hepatectomy and ischemia-reperfusion in mice, based 
on biochemical and morphological analysis. 
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